Codexis (CDXS) FCF Margin (2010 - 2026)

Codexis (CDXS) recorded quarterly FCF Margin of 87.4% in Q1 2026, down 241.64% quarter-over-quarter from 61.7% in Q4 2025, and up 12301.0% on a YoY basis from N/an in Q1 2025.

Codexis (CDXS) FCF Margin (2010 - 2026) Analysis & Trends

Codexis' FCF Margin history runs 17 years deep, the most recent figure standing at 87.4% for Q1 2026.

  • In Q1 2026, FCF Margin rose 12301.0% year-over-year to 87.4%; the TTM figure through Mar 2026 stood at 21.59% (up 10172.0% YoY), while the FY2025 annual figure was 27.57%, up 6294.0% from the prior year.
  • FCF Margin was 87.4% for Q1 2026 at Codexis, down from 61.7% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 77.27% in Q3 2022 to a low of 314.04% in Q2 2023.
  • Historically, FCF Margin has averaged 96.26% across 5 years, with a median of 87.4% in 2026.
  • The sharpest annual moves came in 2023 and 2024: FCF Margin plunged 30331 bps in 2023, then surged 15656 bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 16.47% in 2022, then sank by 787 bps to 146.14% in 2023, then jumped by 42 bps to 85.0% in 2024, then surged by 173 bps to 61.7% in 2025, then plunged by 242 bps to 87.4% in 2026.
  • The last three FCF Margin figures came in at 87.4% (Q1 2026), 61.7% (Q4 2025), and 134.94% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 43.35%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Codexis 236.00 Mn 170.86 Mn 13.18 Mn -87.40%

Historic Data

Download Data
DateValue
Mar 31, 2026 -87.40%
Dec 31, 2025 61.70%
Sep 30, 2025 -134.94%
Jun 30, 2025 -104.01%
Mar 31, 2025 -210.41%
Dec 31, 2024 -85.00%
Sep 30, 2024 -114.92%
Jun 30, 2024 -157.48%
Mar 31, 2024 -47.79%
Dec 31, 2023 -146.14%
Sep 30, 2023 -222.77%
Jun 30, 2023 -314.04%
Mar 31, 2023 -77.27%
Dec 31, 2022 -16.47%
Sep 30, 2022 77.27%
Jun 30, 2022 -10.73%
Mar 31, 2022 -46.05%
Dec 31, 2021 0.57%
Sep 30, 2021 5.82%
Jun 30, 2021 -39.64%